Who will conceive with IVF?

When considering the chances of establishing a healthy ongoing pregnancy after in vitro fertilization (IVF), the cause of infertility plays a relatively minor role. In recent years, there has been a shift from determining the diagnosis to the individual prognosis for a given patient. A number of prognostic factors were identified, which enabled clinicians to appropriately counsel patients. Patient-determined factors are of crucial importance and some are amenable to intervention such as lifestyle and nutritional advice. However, the attention of clinicians remains on seeking adjuvant therapeutic interventions designed to improve the outcomes of IVF treatment. In this article, the patient-determined factors underlying the individual chance of conceiving and the more commonly prescribed empirical medical therapies prescribed to enhance outcomes are reviewed. It is concluded that greater attention to optimizing the health of the couple before starting IVF treatment may be more beneficial than adjuvant medical therapies during treatment. Similar content being viewed by others

Steptoe PC, Edwards RG, Purdy JM (1980) Clinical aspects of pregnancies established with cleaving embryos grown in-vitro. Br J Obstet Gynaecol 87:757–768 Templeton AA, Morris JK, Parslow W et al (1996) Factors that affect the outcome of in-vitro fertilization treatment. Lancet 348:1402–1406 Macklon NS, Stouffer R, Giudice LC, Fauser BCJM (2006) The science behind 25 years of ovarian stimulation for IVF. Endocr Rev 27:170–207 Fauser BCJM, Laven JSE (2006) Female subfertility: evaluation and management. In: DeGroot LJ, Jameson JL (eds) Endocrinology, 5th edn. Elsevier, New York, pp 2949–2962 Bachelot A, Pouly JL, Renon C, Devacchi A, De-Mouzon J (1997) Les antecedents de grossesse fiv. Contracept Fertil Sex 25:507–510 Mahadevan MM, Trounson AO, Leeton JF (1983) The relationship of tubal blockage, infertility of unknown cause, suspected male infertility and endometriosis to success of in-vitro fertilization and embryo transfer. Fertil Steril 40:755–762 Jones HW Jr, Acosta AA, Andrews MC et al (1984) Three years of in vitro fertilization at Norfolk. Fertil Steril 42:826–834 Wardle PG, McLaughlin EA, McDermott A, Mitchell JD, Ray BD, Hull MGR (1985) Endometriosis and ovulatory disorder: reduced fertilization in-vitro compared with tubal and unexplained infertility. Lancet 2:236–239 Simon C, Gutierrez A, Vidal A, de los Santos MJ, Tarin JJ, Remohi J, Pellicer A (1994) Outcome of patients with endometriosis in assisted reproduction: results from in-vitro fertilization and oocyte donation. Hum Reprod 9(4):725–729 Arici A, Oral E, Bulkamez O et al (1996) The effect of endometriosis on implantation: results from the Yale University in vitro fertilization and embryo program. Fertil Steril 6:858–859 Brizek CL, Schlaff S, Pelligrini VA et al (1995) Increased incidence of aberrant morphological phenotypes in human embryogenesis—an association with endometriosis. J Assist Reprod Genet 12:106–112 Pellicer A, Oliviera N, Ruiz A et al (1995) Exploring the mechanism(s) of endometriosis-related infertility: an analysis of embryo development and implantation in assisted reproduction. Hum Reprod 10(Suppl 2):91–97 Garrido N, Navarro J, Remohi J et al (2000) Follicular hormonal environment and embryo quality in women with endometriosis. Hum Reprod Update 6:67–74 Barnhart K, Dunsmoor-Su R, Coutifaris C (2002) Effect of endometriosis on in vitro fertilization. Fertil Steril 77:1148–1155 Strandell A (2003) Evidence based treatment of tubal pathology. Hum Reprod 18(Suppl 1):O–248 Check JH, Lurie D, Callan C, Baker A, Benfer K (1994) Comparison of the cumulative probability of pregnancy after in-vitro fertilization-embryo transfer by infertility factor and age. Fertil Steril 61:257–261 Dor J, Seidman DS, Ben-Shlomo I, Levran D, Ben-Rafael Z, Mashiach S (1996) Cumulative pregnancy rate following in-vitro fertilization: the significance of age and infertility aetiology. Hum Reprod 11:425–428 Aboulghar MA, Mansour RT, Serour GI (1998) Controversies in the modern management of hydrosalpinx. Hum Reprod Update 4:882–890 Johnson NP, Mak W, Sowter MC (2002) Laparoscopic salpingectomy for women with hydrosalpinges enhances the success of IVF: a Cochrane review. Hum Reprod 17:543–548 Strandell A, Lindhard A, Waldenstrom U, Thorburn J (2001) Hydrosalpinx and IVF outcome: cumulative results after salpingectomy in a randomized controlled trial. Hum Reprod 16:2403–2410 Strandell A (2005) The patient with hydrosalpinx. In: Macklon NS (ed) IVF in the medically complicated patient. Taylor & Francis, London, pp 117–138 The ESHRE Capri Workshop Group (1995) Anovulatory infertility. Hum Reprod 10:1549–1553 Rowe PJ, Comhaire FH, Hargreave TB, Mellows H (2000) Female partner. In: Rowe PJ, Comhaire FH, Hargreave TB, Mellows H (eds) WHO manual for the standardized investigation and diagnosis of the infertile couple. Press Syndicate of the University of Cambridge, Cambridge, pp 40–67 van Santbrink EJ, Hop WC, Fauser BC (1997) Classification of normogonadotropic infertility: polycystic ovaries diagnosed by ultrasound versus endocrine characteristics of polycystic ovary syndrome. Fertil Steril 67:452–458 Laven JS, Imani B, Eijkemans MJ, Fauser BC (2002) New approach to polycystic ovary syndrome and other forms of anovulatory infertility. Obstet Gynecol Surv 57:755–767 Eijkemans MJ, Imani B, Mulders AG, Habbema JD, Fauser BC (2003) High singleton live birth rate following classical ovulation induction in normogonadotropic anovulatory infertility (WHO 2). Hum Reprod 18:1–6 Mulders AG, Laven JS, Imani B, Eijkemans MJ, Fauser BC (2003) IVF outcome in anovulatory infertility (WHO group 2)—including polycystic ovary syndrome—following previous unsuccessful ovulation induction. Reprod Biomed Online 7:50–58 Heijnen EM, Eijkemans MJ, Hughes EG, Laven JS, Macklon NS, Fauser BC (2006) A meta-analysis of outcomes of conventional IVF in women with polycystic ovary syndrome. Hum Reprod Update 12:13–21 Collins JA, Burrows EA, Willan AR (1995) The prognosis for live birth among untreated infertile couples. Fertil Steril 64:22–28 Cohlen BJ, Vandekerckhove P, te Velde ER, Habbema JD (2000) Timed intercourse versus intra-uterine insemination with or without ovarian hyperstimulation for subfertility. Cochrane Database Syst Rev (2):CD000360 Forti G, Krausz C (1998) Evaluation and treatment of the infertile couple. J Clin Endocrinol Metab 83:4177–4188 Van Uem JF, Acosta AA, Swanson RJ, Mayer J, Ackerman S, Burkman LJ, Veeck L, McDowell JS, Bernardus RE, Jones HW Jr (1985) Male factor evaluation in in vitro fertilization: Norfolk experience. Fertil Steril 44:375–383 Donnelly ET, Lewis SEM, McNally JA, Thompson W (1998) In vitro fertilization and pregnancy rates: the influence of sperm motility and morphology on IVF outcome. Fertil Steril 70:305–314 Repping S, van Weert JM, Mol BWJ, de Vries JWA, van der Veen F (2002) Use of the total motile sperm count to predict total fertilization failure in in vitro fertilization. Fertil Steril 78:22–28 Devroey P, Vandervorst M, Nagy P, Van Steirteghem A (1998) Do we treat the male of the gamete? Hum Reprod 13(Suppl 1):178–185 Hamberger L, Lundin K, Sjögren A, Söderlund B (1998) Indications for intracytoplasmic sperm injection. Hum Reprod 13(Suppl 1):128–133 Collins JA, Milner RA, Rowe TC (1991) The effect of treatment on pregnancy among couples with unexplained infertility. Int J Fertil 36:145–152 Croucher CA, Lass A, Margara R, Winston RM (1998) Predictive value of the results of a first in-vitro fertilization cycle on the outcome of subsequent cycles. Hum Reprod 13:403–408 Tarlatzis BC, Zepiridis L, Grimbizis G, Bontis J (2003) Clinical management of low ovarian response to stimulation for IVF: a systematic review. Hum Reprod Update 9:61–76 van Hooff MH, Alberda AT, Huisman GJ, Zeilmaker GH, Leerentveld RA (1993) Doubling the human menopausal gonadotrophin dose in the course of an in-vitro fertilization treatment cycle in low responders: a randomized study. Hum Reprod 8:369–373 Karande VC (2003) Managing and predicting low response to standard in vitro fertilization therapy: a review of the options. Treat Endocrinol 2:257–272 Piette C, de Mouzon J, Bachelot A, Spira A (1990) In-vitro fertilization: influence of women’s age on pregnancy rates. Hum Reprod 5:56–59 Tucker MJ, Morton PC, Wright G, Ingargiola PE, Jones AE, Sweitzer CL (1995) Factors affecting success with intracytoplasmic sperm injection. Reprod Fertil Dev 7:229–236 Ashkenazi J, Orvieto R, Gold-Deutch R, Feldberg D, Dicker D, Voliovitch I, Ben-Rafael Z (1996) The impact of woman’s age and sperm parameters on fertilization rates in IVF cycles. Eur J Obstet Gynecol Reprod Biol 66:155–159 Yie SM, Collins JA, Daya S, Hughes E, Sagle M, Younglie EV (1996) Polyploidy and failed fertilization in in-vitro fertilization are related to patients age and gamete quality. Hum Reprod 11:614–617 Cordiero I, Calhaz-Jorge C, Barata M, Leal F, Proenca H, Coelho AM (1995) Repercussao da idade de mulher, de taxa de clivagem e da qualidade embrionaria, na obtencao de graviez por fertilizacao in-vitro. Acta Med Port 8:145–150 Hull MG, Fleming CF, Hughes AO, McDermott A (1996) The age related decline in female fecundity: a quantitative controlled study of implanting capacity and survival of individual embryos after in-vitro fertilization. Fertil Steril 65:783–790 Staessen C, Platteau P, van Assche E, Michiels A, Tournaye H et al (2004) Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomized controlled trial. Hum Reprod 19:2849–2858 Sharif K, Elgendy M, Lashen H, Afnan M (1998) Age and basal follicle stimulating hormone as predictors of in vitro fertilization outcome. Br J Obstet Gynaecol 105:107–112 Chuang CC, Chen CD, Chao KH, Chen SU, Ho HN, Yang YS (2003) Age is a better predictor of pregnancy potential than basal follicle-stimulating hormone levels in women undergoing in vitro fertilization. Fertil Steril 79:63–68 Pellicer A, Lightman A, Diamond MP, Russell JB, DeCherney AH (1987) Outcome of in vitro fertilization in women with low response to ovarian stimulation. Fertil Steril 47:812–815 Jenkins JM, Davies DW, Devonport H, Anthony FW, Gadd SC, Watson RH, Masson GM (1991) Comparison of ‘poor’ responders with ‘good’ responders using a standard buserelin/human menopausal gonadotrophin regime for in-vitro fertilization. Hum Reprod 6:918–921 te Velde ER, Pearson PL (2002) The variability of female reproductive aging. Hum Reprod Update 8:141–154 Scott RT, Opsahl MS, Leonardi MR, Neall GS, Illions EH, Navot D (1995) Life table analysis of pregnancy rates in a general infertility population relative to ovarian reserve and patient age. Hum Reprod 10:1706–1710 Beckers NG, Macklon NS, Eijkemans MJ, Fauser BC (2002) Women with regular menstrual cycles and a poor response to ovarian hyperstimulation for in vitro fertilization exhibit follicular phase characteristics suggestive of ovarian aging. Fertil Steril 78:291–297 de Boer EJ, den Tonkelaar I, te Velde ER, Burger CW, Klip H, van Leeuwen FE (2002) A low number of retrieved oocytes at in vitro fertilization treatment is predictive of early menopause. Fertil Steril 77:978–985 Nikolaou D, Lavery S, Turner C, Margara R, Trew G (2002) Is there a link between an extremely poor response to ovarian hyperstimulation and early ovarian failure? Hum Reprod 17:1106–1111 Lawson R, El-Toukhy T, Kassab A, Taylor A, Braude P, Parsons J, Seed P (2003) Poor response to ovulation induction is a stronger predictor of early menopause than elevated basal FSH: a life table analysis. Hum Reprod 18:527–533 Scott RT, Toner JP, Muasher SJ, Oehninger S, Robinson S, Rosenwaks Z (1989) Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome. Fertil Steril 51:651–654 Toner JP, Philput CB, Jones GS, Muasher SJ (1991) Basal follicle-stimulating hormone level is a better predictor of in vitro fertilization performance than age. Fertil Steril 55:784–791 Creus M, Penarrubia J, Fabregues F, Vidal E, Carmona F, Casamitjana R, Vanrell JA, Balasch J (2000) Day 3 serum inhibin B and FSH and age as predictors of assisted reproduction treatment outcome. Hum Reprod 15:2341–2346 van Rooij IA, Bancsi LF, Broekmans FJ, Looman CW, Habbema JD, te Velde ER (2003) Women older than 40 years of age and those with elevated follicle-stimulating hormone levels differ in poor response rate and embryo quality in in vitro fertilization. Fertil Steril 79:482–488 Bancsi LF, Broekmans FJ, Mol BW, Habbema JD, te Velde ER (2003) Performance of basal follicle-stimulating hormone in the prediction of poor ovarian response and failure to become pregnant after in vitro fertilization: a meta-analysis. Fertil Steril 79(5):1091–1100 Wada I, Hsu CC, Williams G et al (1994) The benefits of low-dose aspirin therapy in women with impaired uterine perfusion during assisted conception. Hum Reprod 9:1954–1957 Empson M, Lassere M, Craig JC, Scott JR (2002) Recurrent pregnancy loss with antiphospholipid antibody: a systematic review of therapeutic trials. Obstet Gynecol 99:135–144 Leitich H, Egater C, Husslein P et al (1997) A meta-analysis of low dose aspirin for the prevention of intrauterine growth retardation. Br J Obstet Gynaecol 104:450–459 Edelman PL (1995) The antiphospholipid syndrome. Curr Opin Obstet Gynecol 7:427–431 Hornstein MD (2000) Antiphospholipid antibodies in patients undergoing IVF: the data do not support testing. Fertil Steril 74:635–636 Stern C, Chamley L, Norris H et al (2003) A randomized, double-blind, placebo-controlled trial of heparin and aspirin for women with in vitro fertilization implantation failure and antiphospholipid or antinuclear antibodies. Fertil Steril 80:376–383 Check JH, Dietterich C, Lurie D et al (1998) A matched study to determine whether low-dose aspirin without heparin improves pregnancy rates following frozen embryo transfer and/or affects endometrial sonographic parameters. J Assist Reprod Genet 15:579–582 Rubinstein M, Marazzi A, Polak de Fried E (1999) Low-dose aspirin treatment improves ovarian responsiveness, uterine and ovarian blood flow velocity, implantation, and pregnancy rates in patients undergoing in vitro fertilization: a prospective, randomized, double-blind placebo-controlled assay. Fertil Steril 71:825–829 Urman B, Mercan R, Alatas C et al (2000) Low-dose aspirin does not increase implantation rates in patients undergoing intracytoplasmic sperm injection: a prospective randomized study. J Assist Reprod Genet 17:586–590 Waldenström U, Hellberg A, Nielsson S (2004) Low-dose aspirin in a short regimen as standard treatment in in vitro fertilization: a randomized, prospective study. Fertil Steril 81:1560–1564 Lok IH, Cheung LP, Yin Leung PH, Haines CJ (2004) Adjuvant low-dose aspirin therapy in poor responders undergoing in vitro fertilization: a prospective, randomized, double-blind, placebo-controlled trial. Fertil Steril 81:556–561 Hefler HL, Greeg AR (2002) Inducible and endothelial nitric oxide synthase: genetic background affects ovulation in mice. Fertil Steril 77:147–151 Kuo RC, Baxter GT, Thompson SH et al (2000) NO is necessary and sufficient for egg activation at fertilization. Nature 406:633–636 Chwalisz K, Garfield RE (2000) Role of nitric oxide in implantation and menstruation. Hum Reprod 15(Suppl 3):96–111 Battaglia C, Salvatori M, Maxia et al (1999) Adjuvant L-arginine treatment for in-vitro fertilization in poor responder patients. Hum Reprod 14:1690–1697 Sher G, Fisch JD (2002) Effect of vaginal sildenafil on the outcome of in vitro fertilization (IVF) after multiple IVF failures attributed to poor endometrial development. Fertil Steril 78:1073–1076 Battaglia C, Regnani G, Marsella T et al (2002) Adjuvant L-arginine treatment in controlled ovarian hyperstimulation: a double-blind, randomized study. Hum Reprod 17:659–665 Ohl J, Lefebvre-Maunoury C, Wittemer C et al (2002) Nitric oxide donors for patients undergoing IVF. A prospective, double-blind, randomized, placebo-controlled trial. Hum Reprod 17:2615–2620 Edwards RG, Steptoe PC, Purdy JM (1980) Establishing full-term human pregnancies using cleaving embryos grown in vitro. Br J Obstet Gynaecol 87:737–756 Donderwinkel PF, Schoot DC, Pache TD et al (1993) Luteal function following ovulation induction in polycystic ovary syndrome patients using exogenous gonadotrophins in combination with a gonadotrophin-releasing hormone agonist. Hum Reprod 8:2027–2032 Smitz J, Ron-El R, Tarlatzis BC (1992) The use of gonadotrophin releasing hormone agonists for in vitro fertilization and other assisted procreation techniques: experience from three centres. Hum Reprod 7(Suppl 1):49–66 Nyboe Andersen A, Popovic-Todorovic B, Schmidt KT et al (2002) Progesterone supplementation during early gestations after IVF or ICSI has no effect on the delivery rates: a randomized controlled trial. Hum Reprod 17:357–361 Costea DM, Gunn LK, Hargreaves C, Howell RJ, Chard T (2000) Delayed luteo-placental shift of progesterone production in IVF pregnancy. Int J Gynaecol Obstet 68:123–129 Macklon NS, Geraedts JP, Fauser BCJM (2002) Conception to ongoing pregnancy: the ‘black box’ of early pregnancy loss. Hum Reprod Update 8:333–343 Baart E, Martini E, Van de Berg I, Macklon NS et al (2006) Preimplantation genetic screening reveals a high incidence of aneuploidy and mosaicism in embryos from young women undergoing IVF. Hum Reprod 21:223–233 Steegers EAP, Wildschut HIJ (2005) Preparing for pregnancy: preconception care. In: Macklon NS (ed) IVF in the medically complicated patient. Taylor & Francis, London, pp 181–203 Lintsen AM, Pasker-de Jong PC, de Boer EJ et al (2005) Effects of subfertility cause, smoking and bodyweight on the success rate of IVF. Hum Reprod 20:1867–1875 Boxmeer JC, Brouns MM, Lindemans J, Martini E, Macklon NS, Steegers-Theunissen RPM (2005) Folic acid treatment affects oocyte environment. J Soc Gynecol Investig 12:24A Boxmeer JC, Smit M, Weber RFA, Lindemans J, Romijn JC, Eijkemans MJC, Macklon NS, Steegers-Theunissen RPM (2006) Seminal plasma cobalamin significantly correlates with sperm concentration. J Soc Gynecol Investig (in press) Author information Authors and Affiliations Rights and permissions About this article Cite this article Macklon, N.S., Fauser, B.C.J.M. Who will conceive with IVF?. Eur Clinics Obstet Gynecol 2, 1–8 (2006). https://doi.org/10.1007/s11296-006-0026-9 Received: Accepted: Published: Issue date: DOI: https://doi.org/10.1007/s11296-006-0026-9